MedTrace Logo

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

NCT00474838 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2013-09-26

No results posted yet for this study

Summary

This randomized controlled prospective study aims to evaluate the efficacy of intensive insulin therapy for long term glycemic control and improvement or preservation of beta cell function in newly diagnosed type 2 diabetes patients.

Conditions

Interventions

DRUG

intensive insulin group

Once daily long acting insulin and preprandial rapid acting insulin injection

DRUG

Oral AntiDiabetic Drug (glimepiride and metformin)

glimepiride and metformin combined therapy

Sponsors & Collaborators

  • Korea University Guro Hospital

    collaborator OTHER

  • Hanyang University

    collaborator OTHER

  • Inha University Hospital

    collaborator OTHER

  • Ajou University

    collaborator OTHER

  • Sanofi

    collaborator INDUSTRY

  • East West Neo Medical Center

    collaborator OTHER

  • The Catholic University of Korea

    collaborator OTHER

  • Jeju National University Hospital

    collaborator OTHER

  • Kyunghee University Medical Center

    lead OTHER

Principal Investigators

  • Jeong-taek Woo, MD, PhD · Kyunghee University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-08-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00474838 on ClinicalTrials.gov